Egyptian International Pharmaceuticals (EIPICO)
Egyptian International Pharmaceuticals (EIPICO) operates in various business sectors.
Market Cap & Net Worth: Egyptian International Pharmaceuticals (EIPICO) (PHAR)
Egyptian International Pharmaceuticals (EIPICO) (EGX:PHAR) has a market capitalization of $14.76K (EGP746.42K) as of March 18, 2026. Listed on the EGX stock exchange, this Egypt-based company holds position #44268 globally and #40 in its home market, demonstrating a -0.59% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Egyptian International Pharmaceuticals (EIPICO)'s stock price EGP80.26 by its total outstanding shares 9300 (9.30K).
Egyptian International Pharmaceuticals (EIPICO) Market Cap History: 2015 to 2026
Egyptian International Pharmaceuticals (EIPICO)'s market capitalization history from 2015 to 2026. Data shows growth from $5.29K to $14.76K (9.30% CAGR).
Egyptian International Pharmaceuticals (EIPICO) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Egyptian International Pharmaceuticals (EIPICO)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PHAR by Market Capitalization
Companies near Egyptian International Pharmaceuticals (EIPICO) in the global market cap rankings as of March 18, 2026.
Key companies related to Egyptian International Pharmaceuticals (EIPICO) by market ranking:
- CHARTER HALL SOC.INF.REIT (F:B6Z0): Ranked #44259 globally with a market cap of $15.54K USD ( €15.14K EUR).
- 251280 (KO:251280): Ranked #44260 globally with a market cap of $15.54K USD ( ₩22.75 Million KRW).
- CPTL & COUNT PROP (BE:C20): Ranked #44269 globally with a market cap of $15.45K USD ( €15.05K EUR).
- OPERA SOFTWARE (MU:OS3): Ranked #44270 globally with a market cap of $15.45K USD ( €15.05K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #44259 | CHARTER HALL SOC.INF.REIT | F:B6Z0 | $15.54K | €1.56 |
| #44260 | 251280 | KO:251280 | $15.54K | ₩2360.00 |
| #44269 | CPTL & COUNT PROP | BE:C20 | $15.45K | €1.66 |
| #44270 | OPERA SOFTWARE | MU:OS3 | $15.45K | €1.58 |
Egyptian International Pharmaceuticals (EIPICO) Historical Marketcap From 2015 to 2026
Between 2015 and today, Egyptian International Pharmaceuticals (EIPICO)'s market cap moved from $5.29K to $ 14.76K, with a yearly change of 9.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | EGP14.76K | +3.56% |
| 2025 | EGP14.26K | +68.81% |
| 2024 | EGP8.44K | +25.78% |
| 2023 | EGP6.71K | -0.03% |
| 2022 | EGP6.72K | -12.86% |
| 2021 | EGP7.71K | -3.57% |
| 2020 | EGP7.99K | -34.63% |
| 2019 | EGP12.23K | -37.68% |
| 2018 | EGP19.62K | +73.59% |
| 2017 | EGP11.30K | +65.20% |
| 2016 | EGP6.84K | +29.41% |
| 2015 | EGP5.29K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Egyptian International Pharmaceuticals (EIPICO) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.76K USD |
| MoneyControl | $14.76K USD |
| MarketWatch | $14.76K USD |
| marketcap.company | $14.76K USD |
| Reuters | $14.76K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.